Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.115
Bid: 0.11
Ask: 0.12
Change: 0.00 (0.00%)
Spread: 0.01 (9.091%)
Open: 0.115
High: 0.115
Low: 0.115
Prev. Close: 0.115
SYN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambay Farm-Out and Funding Arrangements & TVR

5 Dec 2023 07:00

RNS Number : 6085V
Synergia Energy Ltd
05 December 2023
 

RNS Announcement

 

5 December 2023

 

AIM: SYN

Cambay Farm Out and Funding Arrangements

Total Voting Rights

 

Synergia Energy Limited ("Synergia" or the "Company"), is pleased to announce the following update regarding the Cambay Farm Out and funding arrangements.

 

Re: Cambay Farm Out

 

Synergia have been in detailed discussions with a respected Indian operating company (the "Farminee") with the aim of executing a Letter of Intent to establish a farm-out agreement to facilitate the full field development of the Company's Cambay field in which the Company currently holds a 100% working interest.

 

Agreement has been reached in principle, subject to the finalisation of the work programme, final definitive documentation, regulatory approvals (as applicable) and Government of India ("GoI") approval, for the formation of a 50:50% joint venture on the Cambay field. In exchange for the transfer of a 50% working interest in the Cambay PSC, the Farminee is to carry Synergia for the full cost of the agreed work programme, to be completed within 12 months from the date of the GoI approval. The Cambay field would be under joint operatorship by Synergia and the Farminee, with the Farminee acting as lead operator. It is anticipated that the definitive documentation (the Farm-In / Farm-out and joint operating agreements) will be executed within 3 months from the signing of the Letter of Intent.

 

Re: Funding Arrangements

 

The Company has arranged an equity capital raising with clients of Novum Securities Limited of £1.1 million before expenses, through the issue of 1,375,000,000 new fully paid ordinary shares (Placement Shares) at GBP0.08 pence per share (Placement). The Placement will be completed on or around 18 December 2023.

 

In addition, subscribers to the Placement will be offered one free attaching unquoted warrant for every one Placement Share subscribed for, resulting in the issue of an aggregate of 1,375,000,000 unquoted warrants (Placement Warrants). The Placement Warrants are exercisable at GBP 0.14 pence per share on or before 31 December 2026. The issue of the Placement Warrants is subject to shareholder approval, and a general meeting of Synergia shareholders is anticipated to be held in early February 2024.

 

The Placement is being conducted by Novum Securities Limited (Novum) as lead broker to the capital raising. Accordingly, in connection with the Placement, the Company has also agreed to issue 82,500,000 unquoted warrants to Novum, exercisable at GBP 0.14 pence on or before 31 December 2026 (Fee Warrants). The issue of the Fee Warrants is subject to shareholder approval, and, as above, a general meeting of Synergia shareholders is anticipated to be held in early February 2024.

 

 

Funds raised from the Placement are intended to be applied to the Company's working capital base.

 

The Placement Shares will rank pari passu in all respects with the existing shares. Application will be made in due course to the London Stock Exchange for the Placement Shares to be admitted to trading on AIM on or around 18 December 2023 with a further announcement at that time.

 

 

Total Voting Rights

 

Following the issue of all of the Placement Shares, the Company's share capital and total voting rights will comprise 10,497,336,158 shares. The Company does not hold any shares in treasury. Consequently, 10,497,336,158 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

 

Synergia's Chief Executive Officer, Roland Wessel, said:

 

"The Cambay Farm Out agreement is an important milestone for the Company and will provide a path to a self-funded full field development and exploitation of the significant (205 BCF P50) gas reserves on the Cambay license."

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

For and on behalf of Synergia Energy Limited

 

 

Roland Wessel

CEO

 

 

 

 

For further information, please contact:

Investor Enquires

Synergia Energy Ltd

Briana Stayt

Investor Relations

Email: 

bstayt@synergiaenergy.com

Tel: +61 8 9485 3200

Australia

AIM Joint Broker

Panmure Gordon (UK) Ltd

Broker

John Prior / Mark Murphy / Hugh Rich / Freddie Wooding

Tel: +44 (0)20 7886 2500

UK

AIM Joint Broker

Novum Securities

Broker

Colin Rowbury

Email: 

crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Ritchie Balmer / Rory Murphy

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Consulting

Investor Relations

Patrick d'Ancona / Finlay Thomson

Email:

patrick.dancona@vigoconsulting.com

finlay.thomson@vigoconsulting.com

Tel:+ 44 20 7390 0230

UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEZLFBXLLXFBL
Date   Source Headline
25th Apr 20197:00 amRNSTrading Update and Restatement of Accounts
19th Feb 20197:00 amRNSTrading Statement
20th Dec 20184:37 pmRNSDirector/PDMR Shareholding
20th Dec 201811:35 amRNSResult of General Meeting and Change of Name
20th Dec 20187:00 amRNSDirector/PDMR Shareholding
14th Dec 20182:23 pmRNSDirector/PDMR Shareholding
14th Dec 201810:35 amRNSDirector/PDMR Shareholding
5th Dec 20186:27 pmRNSDirector/PDMR Shareholding
5th Dec 201810:16 amRNSHolding(s) in Company
5th Dec 201810:12 amRNSHolding(s) in Company
3rd Dec 20187:00 amRNSHalf-year Report
16th Nov 201811:01 amRNSNotice of Results
5th Oct 20188:00 amRNSTrading Statement
28th Aug 20188:36 amRNSHolding(s) in Company
30th Jul 20182:36 pmRNSResult of AGM
25th Jul 20181:54 pmRNSDirector/PDMR Shareholding
16th Jul 20188:13 amRNSDirector/PDMR Shareholding
9th Jul 20181:46 pmRNSAnnual Financial Report
2nd Jul 20187:00 amRNSFinal Results
22nd Jun 20187:00 amRNSNotice of Results
2nd May 20187:00 amRNSTrading Update
11th Apr 201811:02 amRNSUK Investor Show
16th Mar 20182:22 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSTrading Statement
6th Dec 20177:00 amRNSHalf-year Report
20th Nov 20179:38 amRNSNotice of Results
17th Nov 201710:54 amRNSHolding(s) in Company
5th Oct 20173:48 pmRNSDirector/PDMR Shareholding
3rd Oct 201712:43 pmRNSDirector/PDMR Dealing and Issue of Equity
2nd Oct 20177:00 amRNSTrading Update
1st Aug 20173:42 pmRNSResult of AGM
12th Jul 201711:32 amRNSHolding(s) in Company
11th Jul 20179:19 amRNSHolding(s) in Company
7th Jul 20174:41 pmRNSAnnual Financial Report
3rd Jul 20177:00 amRNSFinal Results
12th Jun 20177:00 amRNSNotice of Results
8th Jun 20175:06 pmRNSHolding(s) in Company
5th Jun 20179:32 amRNSHolding(s) in Company
1st Jun 20174:28 pmRNSApplication for Admission
26th May 20177:00 amRNSPlacing to raise £3.74 million
2nd May 20177:00 amRNSTrading Update
23rd Mar 20178:37 amRNSHolding(s) in Company
27th Feb 20177:00 amRNSPresentation at ShareSoc Growth Company Seminar
20th Feb 20171:30 pmRNSDirector/PDMR Shareholding
13th Feb 20177:00 amRNSTrading Update
30th Jan 20173:45 pmRNSIssue of Equity and Directors' Shareholdings
20th Jan 201711:43 amRNSResult of Scrip Dividend Alternative
12th Jan 20177:00 amRNSGrowth & Innovation Forum
11th Jan 20172:38 pmRNSDirector/PDMR Shareholding
29th Dec 201610:15 amRNSScrip Dividend Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.